Skip to content
Home
About Us
Why LinKinVax ?
Science
Leadership Team
Partnering & featured deal
Company Responsability
Research & development
Science
Our products
Linkinvax pipeline
Medias
News
Press releases
SUBSCRIBE TO UPDATE
Investors
A unique project
SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us
Menu
Home
About Us
Why LinKinVax ?
Science
Leadership Team
Partnering & featured deal
Company Responsability
Research & development
Science
Our products
Linkinvax pipeline
Medias
News
Press releases
SUBSCRIBE TO UPDATE
Investors
A unique project
SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us
Home
About Us
Why LinKinVax ?
Science
Leadership Team
Partnering & featured deal
Company Responsability
Research & development
Science
Our products
Linkinvax pipeline
Medias
News
Press releases
SUBSCRIBE TO UPDATE
Investors
A unique project
SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us
Menu
Home
About Us
Why LinKinVax ?
Science
Leadership Team
Partnering & featured deal
Company Responsability
Research & development
Science
Our products
Linkinvax pipeline
Medias
News
Press releases
SUBSCRIBE TO UPDATE
Investors
A unique project
SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us
Archives
LinKinVax has the trust of world-class partners and investors.
News & events
September 19, 2023
Vaccin thérapeutique : un premier patient traité pour un canceroropharyngé HPV-positif dans un essai à Gustave Roussy
CLICK HERE
PDF LINK
VIEW MORE
LinKinVax and Gustave Roussy announced first patient dosedin Phase I/IIa clinical study on HPV.DCVax in HPV-positiveoropharyngeal cancer
Click here
LinKinVax and Gustave Roussy announced first patient dosedin Phase I/IIa clinical study on HPV.DCVax in HPV-positiveoropharyngeal cancer
Click here
LinKinVax et Gustave Roussy annoncent un premier patienttraité dans l’essai clinique HPV.DCVax de phase I/IIa dans lecancer oropharyngé HPV-positif
Click here
LinKinVax et Gustave Roussy annoncent un premier patienttraité dans l’essai clinique HPV.DCVax de phase I/IIa dans lecancer oropharyngé HPV-positif
Click here
LinKinVax completes first batch production of “pancov”,its next generation multi-variant vaccine against covid and other coronaviruses
Click here
LinKinVax completes first batch production of “pancov”,its next generation multi-variant vaccine against covid and other coronaviruses
Click here
LinKinVax finalise la production du premier lot d’un vaccin de nouvelle génération, contre la covid et les virus de la même famille.
Click here
LinKinVax finalise la production du premier lot d’un vaccin de nouvelle génération, contre la covid et les virus de la même famille.
Click here
press releases
No data was found
VIEW MORE
